CMS Extends National Medicare Coverage For Transcatheter Mitral Valve Repair
Executive Summary
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.
You may also be interested in...
TCT 2022: Edwards Ready To Take On Abbott In Mitral Repair Market With ‘Premium’ Device
Edwards Lifesciences is ramping up US commercialization of its Pascal Precision mitral valve transcatheter edge-to-edge repair device, the first US competitor for Abbott’s MitraClip. The FDA approved Pascal Precision earlier than the company expected, based on results of the CLASP IID trial.
FDA Warns Of Clip Lock Risk With Abbott's MitraClip
The US FDA is alerting providers about a potential clip lock malfunction with Abbott’s MitraClip, a device used to treat a disorder involving the heart’s mitral valve.
Cardio Catch-Up: More Conferences, More New Data From Abbott And Medtronic
Medtech Insight’s Cardiovascular Catch-Up highlights some of the recent news on cardiovascular tech innovations in the last two months. This edition focuses on news from conferences, held over the last two months, including the Heart Rhythm Society and the TVT Structural Heart Summit.